ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 161 filers reported holding ANTARES PHARMA INC in Q4 2019. The put-call ratio across all filers is 5.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $15,069,000 | +14.2% | 3,863,275 | +4.5% | 3.80% | +26.2% |
Q4 2021 | $13,193,000 | -0.4% | 3,695,475 | -1.0% | 3.01% | -6.4% |
Q3 2021 | $13,240,000 | -15.6% | 3,733,250 | +1.0% | 3.22% | -13.6% |
Q2 2021 | $15,680,000 | +5.9% | 3,696,250 | -2.7% | 3.72% | -4.6% |
Q1 2021 | $14,812,000 | +5.0% | 3,799,580 | +3.0% | 3.90% | -12.4% |
Q4 2020 | $14,103,000 | +39.9% | 3,688,805 | -2.3% | 4.46% | +21.4% |
Q3 2020 | $10,083,000 | -5.7% | 3,774,885 | -5.0% | 3.67% | -8.7% |
Q2 2020 | $10,692,000 | -1.5% | 3,972,565 | -13.6% | 4.02% | -19.5% |
Q1 2020 | $10,852,000 | -70.6% | 4,598,329 | -41.4% | 4.99% | -27.7% |
Q4 2019 | $36,885,000 | +231.6% | 7,847,940 | +136.0% | 6.90% | +38.2% |
Q3 2019 | $11,122,000 | +5.1% | 3,324,890 | +3.4% | 4.99% | +3.3% |
Q2 2019 | $10,583,000 | +9.7% | 3,216,575 | +1.0% | 4.83% | +4.0% |
Q1 2019 | $9,650,000 | +14.6% | 3,184,955 | +2.9% | 4.65% | -10.2% |
Q4 2018 | $8,422,000 | – | 3,096,355 | – | 5.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |